These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7818127)

  • 1. Alcuronium: a pharmacodynamic and pharmacokinetic update.
    Diefenbach C; Künzer T; Buzello W; Theisohn M
    Anesth Analg; 1995 Feb; 80(2):373-7. PubMed ID: 7818127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacokinetics of alcuronium chloride in man.
    Walker J; Shanks CA; Triggs EJ
    Eur J Clin Pharmacol; 1980 Jun; 17(6):449-57. PubMed ID: 7398736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The dose-response relationship and time course of the neuromuscular blockade by alcuronium].
    Pühringer F; Adler R; Mitterschiffthaler G; Koller J; Mair P; Khünl-Brady KS; Agoston S
    Anaesthesist; 1990 Oct; 39(10):508-12. PubMed ID: 1980578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacodynamics of alcuronium in the elderly.
    Kent AP; Hunter JM
    Anaesthesia; 1991 Apr; 46(4):271-4. PubMed ID: 2024743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of respiration after neuromuscular blockade with alcuronium.
    Astley BA; Hughes R; Payne JP
    Br J Anaesth; 1987 Feb; 59(2):206-10. PubMed ID: 3030384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance requirement of alcuronium in paediatric patients.
    Meretoja OA; Brown TC
    Anaesth Intensive Care; 1990 Nov; 18(4):452-4. PubMed ID: 2268008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tetanus-Myomechanographic measurement of receptor liberation by pyridostigmine in neuromuscular block produced by d-tubocurarine, gallamine, pancuronium or alcuronium (author's transl)].
    Barth L; Dannhorn R
    Prakt Anaesth; 1979 Aug; 14(4):303-12. PubMed ID: 493225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the action kinetics of alcuronium and vecuronium by electromyographic monitoring].
    Lapeyre G; Chevreaud C; Manel J; Mialhe C; Laxenaire MC
    Ann Fr Anesth Reanim; 1988; 7(1):3-7. PubMed ID: 2894789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of the reversal time of competitive neuromuscular block by anticholinesterases.
    Beemer GH; Bjorksten AR; Dawson PJ; Dawson RJ; Heenan PJ; Robertson BA
    Br J Anaesth; 1991 Apr; 66(4):469-75. PubMed ID: 2025474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative neuromuscular block following atracurium or alcuronium in children.
    Meretoja OA; Gebert R
    Can J Anaesth; 1990 Oct; 37(7):743-6. PubMed ID: 2171792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular blocking potency of fazadinium in man.
    Hashimoto Y; Shima T; Matsukawa S; Satou M
    Anaesthesia; 1979 Jan; 34(1):10-3. PubMed ID: 34334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Priming and the onset of neuromuscular blockade with alcuronium.
    Black AM; Hutton P; el-Hassan KM; Morgan G; Clutton-Brock TH
    Br J Anaesth; 1986 Aug; 58(8):827-33. PubMed ID: 3730230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cardiopulmonary bypass on the plasma concentrations of fentanyl and alcuronium.
    Miller RS; Peterson GM; McLean S; Möller C
    J Clin Pharm Ther; 1997 Jun; 22(3):197-205. PubMed ID: 9447475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of alcuronium in children with acyanotic and cyanotic cardiac disease undergoing cardiopulmonary bypass surgery.
    Weekes LM; Keneally JP; Goonetilleke PH; Ramzan IM
    Paediatr Anaesth; 1995; 5(6):369-74. PubMed ID: 8597969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical neuromuscular pharmacology of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
    Belmont MR; Lien CA; Quessy S; Abou-Donia MM; Abalos A; Eppich L; Savarese JJ
    Anesthesiology; 1995 May; 82(5):1139-45. PubMed ID: 7741288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of neuromuscular function and postoperative morbidity following blockade by atracurium, alcuronium and vecuronium.
    Kong KL; Cooper GM
    Anaesthesia; 1988 Jun; 43(6):450-3. PubMed ID: 2900608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug.
    Savarese JJ; Ali HH; Basta SJ; Embree PB; Scott RP; Sunder N; Weakly JN; Wastila WB; el-Sayad HA
    Anesthesiology; 1988 May; 68(5):723-32. PubMed ID: 2967039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between atracurium and alcuronium for muscle relaxation during laparoscopy.
    Fourie PJ; Lambert PA; Versace M; Bodemer WP; van der Merwe CA; Lessing AJ
    S Afr Med J; 1986 Apr; 69(9):553-5. PubMed ID: 2939574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis.
    Khalil M; D'Honneur G; Duvaldestin P; Slavov V; De Hys C; Gomeni R
    Anesthesiology; 1994 Jun; 80(6):1241-7. PubMed ID: 8010470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of intercompartmental disposition and excretion of tubocurarine, gallamine, alcuronium and pancuronium in patients with normal and impaired renal function.
    Buzello W; Agoston S
    Anaesthesist; 1978 Jul; 27(7):319-21. PubMed ID: 150805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.